Deval A. Lashkari

Deval Lashkari has over 25 years’ experience in various senior management positions in the life science industry, developing and commercializing novel technologies. Prior to Telegraph Hill Partners (THP), Deval gained corporate and business development experience through management positions at Incyte, Synteni, Operon Technologies, and Genometrix. At THP, Deval focuses on life science and diagnostics investments. Deval has represented THP on the boards of AcroMetrix, Active Motif, Althea Technologies, AltheaDx, Applied Precision, Aurora Discovery, and NEXUS Biosystems to name a few. Deval received a BA from the University of California, Berkeley and a Ph.D. from Stanford University.